|
|
|
|
||
Re: Navidea Biopharmaceuticals to Present..during P1/P2 RA trial TIL incidentally identified tumor/or other inflammation in subject for which they were treated.. will be an add on later to Label..eomHow would that go over with CAH and their rights to sell Lymphoseek as a cancer diagnostic in N A. Hell, maybe another law suit in the works if Navidea does include it on the label for RA, assuming it ever gets to that point. |
return to message board, top of board |